Company intelligence / Profile preview

Luxin Venture Capital Group

Jinan, Shandong, Chinaforbes.com ↗

Ownership: Private
Development stage: Other

Overview

Luxin Venture Capital Group is one of China’s leading venture capital and private equity firms, focusing on investments across advanced manufacturing, semiconductors, new materials, new energy, information technology, biotechnology, pharmaceuticals, medicine and healthcare among other sectors. The group manages multiple funds and has made over 90 investments including in the medical and pharmaceutical industries. It does not develop drugs or therapies directly but acts as an institutional investor supporting innovation-driven companies at various stages from start-up to pre-IPO.

Industry: Investors

Beyond the preview

Go deeper on Luxin Venture Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luxin Venture Capital Group.

Explore the full profile